Intercept Pharmaceuticals Inc (ICPT)
45.96
+2.10 +4.79%
NASDAQ
Jul 10, 11:48
Delayed 2m
USD
Intercept Pharmaceuticals Key Stats
Stock Price Performance
| 1 Month Price Returns (Daily) | Upgrade |
| 3 Month Price Returns (Daily) | Upgrade |
| 6 Month Price Returns (Daily) | Upgrade |
| Year to Date Price Returns (Daily) | Upgrade |
| 1 Year Price Returns (Daily) | Upgrade |
| 3 Year Price Returns (Daily) | Upgrade |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| 52-Week High Date | Dec. 26, 2019 |
| 52-Week Low Date | Jul. 09, 2020 |
Dividends and Shares
| Shares Outstanding | 32.94M |
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Cash Dividend Payout Ratio | Upgrade |
| Payout Ratio | Upgrade |
| Latest Dividend Pay Date | -- |
| Next Ex-Dividend Date | -- |
| Last Split Factor | -- |
| Last Split Date | -- |
Risk Metrics
Estimates
Income Statement
Balance Sheet
Cash Flow Statement
| Cash from Financing (TTM) | 456.61M |
| Cash from Investing (TTM) | -211.64M |
| Cash from Operations (TTM) | -251.92M |
| Capital Expenditures (TTM) | Upgrade |
Common Size Statements
| Net Income (% of Quarterly Revenues) | Upgrade |
| Net Income (% of Annual Revenues) | Upgrade |
Earnings Quality
| Accruals (Quarterly) | Upgrade |
| Beneish M-Score (Annual) | Upgrade |
Profitability
| Gross Profit Margin (Quarterly) | 98.83% |
| Profit Margin (Quarterly) | -128.0% |
| EBITDA Margin (TTM) | Upgrade |
| Operating Margin (TTM) | Upgrade |
Management Effectiveness
Current Valuation
Liquidity and Solvency
Employee Count Metrics
| Total Employees (Annual) | Upgrade |
| Revenue Per Employee (Annual) | Upgrade |
| Net Income Per Employee (Annual) | Upgrade |
